Sotrovimab
Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19. It has antiviral activity, induces serum neutralization of BQ.1 and antibody-dependent cytotoxicity, and may be used to study viral infections.
Product Specifications
CAS Number
2423014-07-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
SARS-CoV
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1033312-01 0.02 mg (E-Coli)
Recombinant Clostridium botulinum Glucosamine-6-phosphate deaminase (nagB)
Ask
View Details MBS1033312-02 0.1 mg (E-Coli)
Recombinant Clostridium botulinum Glucosamine-6-phosphate deaminase (nagB)
Ask
View Details 
MBS1033312-03 0.02 mg (Yeast)
Recombinant Clostridium botulinum Glucosamine-6-phosphate deaminase (nagB)
Ask
View Details MBS1033312-04 0.1 mg (Yeast)
Recombinant Clostridium botulinum Glucosamine-6-phosphate deaminase (nagB)
Ask
View Details